Cargando…

Patterns of First-Line Systemic Therapy Delivery and Outcomes in Advanced Epithelial Ovarian Cancer in Ontario

Background: First-line treatment of epithelial ovarian cancer (EOC) consists of a combination of cytoreductive surgery and platinum-based chemotherapy. Recently, targeted therapies such as bevacizumab have been shown to improve oncologic outcomes in a subset of a high-risk population. The objective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shiru L., Chan, Wing C., Bouchard-Fortier, Geneviève, Lheureux, Stephanie, Ferguson, Sarah E., Krzyzanowska, Monika K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406672/ https://www.ncbi.nlm.nih.gov/pubmed/36005210 http://dx.doi.org/10.3390/curroncol29080472

Ejemplares similares

Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers
por: Kasherman, Lawrence, et al.
Publicado: (2022)

Docetaxel-carboplatin as first line chemotherapy for epithelial ovarian cancer
por: Vasey, P A, et al.
Publicado: (2001)

Who should be offered non-radical surgery for early-stage cervical cancer?
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2015)

Salpingectomy and the Risk of Ovarian Cancer in Ontario
por: Giannakeas, Vasily, et al.
Publicado: (2023)

Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic
por: Walker, Meghan J., et al.
Publicado: (2022)

Reducing dexamethasone antiemetic prophylaxis during the COVID-19 pandemic: recommendations from Ontario, Canada
por: Grant, Robert C., et al.
Publicado: (2020)

Rucaparib: a novel PARP inhibitor for BRCA advanced ovarian cancer
por: Colombo, Ilaria, et al.
Publicado: (2018)

Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations
por: Madariaga, Ainhoa, et al.
Publicado: (2019)

Ovarian cancer treatment: The end of empiricism?
por: Lheureux, Stephanie, et al.
Publicado: (2015)

The Delivery of Patient Care in Ontario's Family Health Teams during the First Wave of the COVID-19 Pandemic
por: Ashcroft, Rachelle, et al.
Publicado: (2021)

Hexamethylmelamine as Consolidation Treatment for Patients with Advanced Epithelial Ovarian Cancer in Complete Response after First-Line Chemotherapy
por: Kwon, Yong Soon, et al.
Publicado: (2009)

Evaluation of leptin serum concentrations during surgery and first-line chemotherapy in primary epithelial ovarian cancer patients
por: Grabowski, Jacek Przemyslaw, et al.
Publicado: (2014)

Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach
por: Montgomery, Nicole, et al.
Publicado: (2020)

An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline: Consolidation or Maintenance Systemic Therapy for Newly Diagnosed Stage II, III, or IV Epithelial Ovary, Fallopian Tube, or Primary Peritoneal Carcinoma
por: Hirte, Hal, et al.
Publicado: (2021)

Spatial and temporal patterns of smoking prevalence in Ontario
por: Meng, Gang, et al.
Publicado: (2015)

Utilization Rates of Pancreatectomy, Radical Prostatectomy, and Nephrectomy in New York, Ontario, and New South Wales, 2011 to 2018
por: Pang, Hilary Y. M., et al.
Publicado: (2021)

A population-based study comparing patterns of care delivery on the quality of care for persons living with HIV in Ontario
por: Kendall, Claire E, et al.
Publicado: (2015)

Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
por: Bellier, Charlotte, et al.
Publicado: (2023)

Inoperable Bowel Obstruction in Ovarian Cancer: Prevalence, Impact and Management Challenges
por: Gonzalez-Ochoa, Eduardo, et al.
Publicado: (2022)

Fertility-sparing surgery for the management of young women with embryonal rhabdomyosarcoma of the cervix: A case series
por: Bouchard-Fortier, Geneviève, et al.
Publicado: (2016)

A tale of two time periods: ovarian cancer trends in Ontario
por: Elit, L., et al.
Publicado: (2007)

First-line chemotherapy for ovarian cancer – the controversy continues
por: Kaye, S B
Publicado: (2002)

Update on first-line treatment of advanced ovarian carcinoma
por: Kemp, Z, et al.
Publicado: (2013)

Characterization of three new serous epithelial ovarian cancer cell lines
por: Ouellet, Véronique, et al.
Publicado: (2008)

DNA Methylation Profiles of Ovarian Epithelial Carcinoma Tumors and Cell Lines
por: Houshdaran, Sahar, et al.
Publicado: (2010)

Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer
por: Veneziani, Ana C., et al.
Publicado: (2023)

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy
por: Smoter, Marta, et al.
Publicado: (2013)

Omission of adjuvant therapy in stage I clear cell ovarian cancer: Review of the BC Cancer experience
por: Liu, Shiru L., et al.
Publicado: (2019)

Gynecologic oncology and surgical oncology treatment modifications, cancellations or delays in response to the COVID-19 pandemic in public versus private cancer centers in North America
por: Piedimonte, Sabrina, et al.
Publicado: (2021)

Prevalence and patterns of multimorbidity among linguistic groups of patients receiving home care in Ontario: a retrospective cohort study
por: Batista, Ricardo, et al.
Publicado: (2023)

Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer
por: Marastoni, Stefano, et al.
Publicado: (2022)

Ovarian Cancer and BRCA1/2 Testing: Opportunities to Improve Clinical Care and Disease Prevention
por: Karakasis, Katherine, et al.
Publicado: (2016)

The importance of Calanus glacialis for the feeding success of young polar cod: a circumpolar synthesis
por: Bouchard, Caroline, et al.
Publicado: (2020)

Ontario
Publicado: (1995)

Ontario
Publicado: (1897)

Outcomes for the First Year of Ontario's Birth Center Demonstration Project
por: Sprague, Ann E., et al.
Publicado: (2018)

First-line treatment of ovarian cancer: questions and controversies to address
por: Ledermann, Jonathan A.
Publicado: (2018)

Carboplatin sensitivity in epithelial ovarian cancer cell lines: The impact of model systems
por: Patra, Bishnubrata, et al.
Publicado: (2020)

Pattern of triple negative epithelial ovarian cancer in indigenous African women
por: Ajani, Mustapha Akanji, et al.
Publicado: (2016)

Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer
por: Kraus, Fabian B. T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gfgj69am6glg2862pteq3o7vvv